<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04265885</url>
  </required_header>
  <id_info>
    <org_study_id>2020PI033</org_study_id>
    <nct_id>NCT04265885</nct_id>
  </id_info>
  <brief_title>Gender Dysphoria and Transition</brief_title>
  <acronym>DyGePeT</acronym>
  <official_title>Gender Dysphoria and Transition: Testimony From Transgender People</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Lorraine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Persons with gender dysphoria present the difficulties of access to health care. Little time&#xD;
      is devoted to education of health professionals about the care of transgender persons.&#xD;
      According to the proposal of the French Ministry of Social Affairs and Health there is a need&#xD;
      to increase knowledge in this area and to improve the care of transgender people including&#xD;
      prevention and screening.&#xD;
&#xD;
      Similarly, little is known about social and medical needs of the transgender population.&#xD;
&#xD;
      This project proposes to illustrate gender dysphoria through testimonies of transgender&#xD;
      people with the aim to increase the investigator's understanding aout the needs and the&#xD;
      desires of this population and to describe the process of medical and social transition.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Illustrate the real-life experiences of transgender people</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Gender Dysphoria</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collection of testimonies from transgender people</intervention_name>
    <description>guided interview</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The participation to the study will be offered consecutively to adult subjects with gender&#xD;
        dysphoria followed in the department of endocrinology, diabetology and nutrition of the&#xD;
        University Hospital of Nancy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Person affiliated to a social security system&#xD;
&#xD;
          -  Person having received complete information on the organisation of the research and&#xD;
             having signed the informed consent&#xD;
&#xD;
          -  Person having carried out a prior clinical examination adapted to the research&#xD;
&#xD;
          -  Age&gt; 18 years&#xD;
&#xD;
          -  Diagnosis of gender incongruence (dysphoria) according to the international&#xD;
             classification of diseases, revision 11&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe, uncontrolled psychiatric or somatic illness&#xD;
&#xD;
          -  Substance and alcohol addiction&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Eva Feigerlova, MD, PhD</last_name>
    <phone>+33(0)83155032</phone>
    <email>e.feigerlova@chru-nancy.fr</email>
  </overall_contact>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 10, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2020</study_first_posted>
  <last_update_submitted>August 7, 2020</last_update_submitted>
  <last_update_submitted_qc>August 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Gender Dysphoria</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

